title: Neurodevelopmental disorders. New hope for a devastating neurological disorder.
authors.forename: Greg
authors.initials: G
authors.lastname: Miller
mesh_terms: D017204:Angelman Syndrome / Q000188:drug therapy* / Q000235:genetics* / Q000628:therapy; D000818:Animals; D001921:Brain / Q000166:cytology / Q000187:drug effects; D002166:Camptothecin / Q000031:analogs & derivatives* / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D005786:Gene Expression Regulation; D015316:Genetic Therapy; D006801:Humans; D000077146:Irinotecan; D051379:Mice; D009474:Neurons / Q000187:drug effects / Q000502:physiology; D019772:Topotecan / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D015533:Transcriptional Activation; D044767:Ubiquitin-Protein Ligases / Q000235:genetics* / Q000378:metabolism
chemical_list: D000077146:Irinotecan; D019772:Topotecan; C471639:UBE3A protein, human; D044767:Ubiquitin-Protein Ligases; D002166:Camptothecin